Savvy Trades and Investments

[abh3vt]

HALO. This is a biotech company that I've been following/own and like its potential. Just announced another partnership with its Enhanze drug delivery technology:
https://www.prnewswire.com/news-releases/halozyme-and-acumen-pharmaceuticals-enter-global-collaboration-and-non-exclusive-license-agreement-for-the-enhanze-technology-in-alzheimers-disease-301978022.html

They also report after the bell today. HALO has a tough Q3 y/y comp, but the expectation for future growth appears pretty solid. If accurate, the stock looks undervalued. It's been sold off like a lot of biotech has been this year, but they are solidly non-GAAP profitable and generate decent cash from operations.